PALO ALTO, Calif., Oct. 25 /PRNewswire/ -- PhoenixBio, a venture-backed biotechnology company with a proprietary transplant mouse technology (PXB Mouse), and InfiniteBio, a global lifescience business consulting firm, announced a strategic alliance today.
Through this alliance, InfiniteBio will market and sell the PXB Mouse technology to customers in North America. PXB Mouse offers pharmaceutical and biotechnology companies a means to predict human drug ADME properties at an early stage of drug development.
“We selected InfiniteBio as our strategic marketing partner, because of their strong technical and marketing expertise in biotechnology as well as extensive network in biotechnology and pharmaceutical industry worldwide,” says Kenji Kuramoto, President of PhoenixBio. “The North American market is critical for our future success, and we are very excited about a close working relationship with InfiniteBio.”
“Pharmaceutical industry is under pressure to reduce the time and cost of drug development and to predict drug efficacy and toxicity as early as possible. PXB Mouse technology might change the paradigm dramatically and accelerate drug discovery,” says Akiko Futamura, PhD, President and Chief Executive Officer of InfiniteBio. “We are already seeing a strong demand for this technology and we are excited that PhoenixBio has chosen us as its sales and marketing partner for the North American market.”
ABOUT PHOENIXBIO, CO., LTD.
PhoenixBio, www.phoenixbio.co.jp , is a venture-backed biotechnology company located in Hiroshima, Japan, whose main business is to produce PXB mice based on its proprietary methods and to offer preclinical studies using PXB mice. PXB Mouse is a chimeric mouse whose liver is replaced with human hepatocytes. The technology is based on research by Professor Yoshizato of Hiroshima University, who is one of the world’s leading researchers in biology. PhoenixBio is a privately held company.
ABOUT INFINITEBIO, INC.
InfiniteBio, www.infinitebio.com , is a strategic consulting company in biotechnology, located in Palo Alto, California. InfiniteBio clients range from start-up companies to large fortune 500 corporations. With strong expertise and networks in lifescience industry, InfiniteBio helps clients bring new technologies and products to the global market.
InfiniteBio, Inc.
CONTACT: Akiko Futamura, Ph.D., President & CEO of InfiniteBio,+1-650-327-7082
